GlobalData on MSN2d
Tumour-on-chip model could help discover pancreatic cancer therapies
A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...
F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions ...
Medscape11d
Novel Blood Test Enables Early Pancreatic Cancer Detection
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
Hosted on MSN2d
Tumour-on-Chip Model Supports Preclinical Drug Development on Pancreatic Cancer
The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer ...
ImmunityBio Shares Up, FDA Gives RMAT Designation for Treatment of Lymphopenia in Cancer Patients
ImmunityBio shares advanced 17% to $3.34 after the company said the Food and Drug Administration awarded a regenerative medicine advanced therapy designation for Anktiva and CAR-NK for the reversal of ...
Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effectsRamat Gan, Israel, March 03, ...
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
TNG462 granted Orphan Drug Designation for treatment of pancreatic cancer –– Investigational New Drug (IND) application for TNG456, a ...